{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:45:01Z","timestamp":1793994301358,"version":"4.8.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/08418-6"],"award-info":[{"award-number":["2023\/08418-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89434-x","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T21:32:23Z","timestamp":1755811943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Discovery of clocinizine as a potential oral drug against Schistosoma mansoni infection"],"prefix":"10.1038","volume":"15","author":[{"given":"Thalitta","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thain\u00e1 R.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Siegl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via B.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina C.","family":"Esp\u00edrito-Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo S.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"89434_CR1","unstructured":"WHO guideline on control. and elimination of human schistosomiasis. https:\/\/www.who.int\/publications\/i\/item\/9789240041608"},{"key":"89434_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus, D. P. et al. Schistosomiasis. Nat. Rev. Dis. Primers. 4, 13 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"89434_CR3","unstructured":"World Health Organization. Ending the Neglect to Attain the Sustainable Development Goals: A road map for Neglected Tropical Diseases 2021\u20132030 (World Health Organization, 2020). https:\/\/www.who.int\/publications\/i\/item\/9789240010352"},{"key":"89434_CR4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1021\/acsinfecdis.0c00542","volume":"7","author":"T Spangenberg","year":"2021","unstructured":"Spangenberg, T. Alternatives to praziquantel for the prevention and control of schistosomiasis. ACS Infect. Dis. 7, 939\u2013942 (2021).","journal-title":"ACS Infect. Dis."},{"key":"89434_CR5","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1016\/j.drudis.2022.04.004","volume":"27","author":"LLG Ferreira","year":"2022","unstructured":"Ferreira, L. L. G., de Moraes, J. & Andricopulo, A. D. Approaches to advance drug discovery for neglected tropical diseases. Drug Discov Today. 27, 2278\u20132287 (2022).","journal-title":"Drug Discov Today"},{"issue":"19","key":"89434_CR6","first-page":"e01208","volume":"63","author":"DB Roquini","year":"2019","unstructured":"Roquini, D. B. et al. Promethazine exhibits antiparasitic properties in vitro and reduces worm burden, egg production, hepato-, and splenomegaly in a schistosomiasis animal model. Antimicrob. Agents Chemother. 63 (19), e01208 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"89434_CR7","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s13071-020-04140-z","volume":"13","author":"RP Xavier","year":"2020","unstructured":"Xavier, R. P. et al. H1-antihistamines as antischistosomal drugs: in vitro and in vivo studies. Parasit. Vectors. 13, 278 (2020).","journal-title":"Parasit. Vectors"},{"key":"89434_CR8","doi-asserted-by":"publisher","first-page":"31159","DOI":"10.1021\/acsomega.4c04773","volume":"9","author":"DB Roquini","year":"2024","unstructured":"Roquini, D. B. et al. Antihistamines H1 as potential anthelmintic agents against the zoonotic parasite Angiostrongylus cantonensis. ACS Omega. 9, 31159\u201331165 (2024).","journal-title":"ACS Omega"},{"key":"89434_CR9","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1590\/S0365-05962010000200010","volume":"85","author":"P Criado","year":"2010","unstructured":"Criado, P., Criado, R., Maruta, C. & Filho, C. D. Histamine, histamine receptors and antihistamines: New concepts. Bras. Dermatol. 85, 195\u2013210 (2010).","journal-title":"Bras. Dermatol."},{"key":"89434_CR10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4155\/fmc-2020-0311","volume":"13","author":"TC Silva","year":"2021","unstructured":"Silva, T. C. et al. New evidence for tamoxifen as an antischistosomal agent: In vitro, in vivo and target fishing studies. Future Med. Chem. 13, 945\u2013957 (2021).","journal-title":"Future Med. Chem."},{"key":"89434_CR11","doi-asserted-by":"publisher","first-page":"e01722","DOI":"10.1128\/AAC.01722-18","volume":"63","author":"RA Guerra","year":"2019","unstructured":"Guerra, R. A. et al. In vitro and in vivo studies of spironolactone as an antischistosomal drug capable of clinical repurposing. Antimicrob. Agents Chemother. 63, e01722\u2013e01718 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"89434_CR12","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/ph14070686","volume":"14","author":"R Porto","year":"2021","unstructured":"Porto, R. et al. Antiparasitic properties of cardiovascular agents against human intravascular parasite Schistosoma mansoni. Pharmaceuticals (Basel). 14, 686 (2021).","journal-title":"Pharmaceuticals (Basel)"},{"key":"89434_CR13","doi-asserted-by":"publisher","first-page":"350","DOI":"10.2165\/00002018-199410050-00002","volume":"10","author":"FE Simons","year":"1994","unstructured":"Simons, F. E. H1-receptor antagonists. Comparative tolerability and safety. Drug Saf. 10, 350\u2013380 (1994).","journal-title":"Drug Saf."},{"key":"89434_CR14","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","volume":"128","author":"FE Simons","year":"2011","unstructured":"Simons, F. E. & Simons, K. J. Histamine and H1-antihistamines: Celebrating a century of progress. J. Allergy Clin. Immunol. 128, 1139\u20131150 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"89434_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4155\/fmc-2017-0112","volume":"10","author":"EM Lago","year":"2018","unstructured":"Lago, E. M. et al. Antischistosomal agents: State of art and perspectives. Future Med. Chem. 10, 89\u2013120 (2018).","journal-title":"Future Med. Chem."},{"key":"89434_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1080\/17425247.2022.2051477","volume":"19","author":"AC Mengarda","year":"2022","unstructured":"Mengarda, A. C., Iles, B., Longo, J. P. & de Moraes, J. Recent trends in praziquantel nanoformulations for helminthiasis treatment. Expert Opin. Drug Deliv. 19, 383\u2013393 (2022).","journal-title":"Expert Opin. Drug Deliv"},{"key":"89434_CR17","doi-asserted-by":"publisher","first-page":"e1852","DOI":"10.1002\/wnan.1852","volume":"15","author":"AC Mengarda","year":"2023","unstructured":"Mengarda, A. C., Iles, B., Longo, J. P. & de Moraes, J. Recent approaches in nanocarrier-based therapies for neglected tropical diseases. Wiley Interdiscip Rev. Nanomed. Nanobiotechnol. 15, e1852 (2023).","journal-title":"Wiley Interdiscip Rev. Nanomed. Nanobiotechnol."},{"key":"89434_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0021-5198(19)43508-7","volume":"43","author":"N Kubo","year":"1987","unstructured":"Kubo, N., Shirakawa, O., Kuno, T. & Tanaka, C. Antimuscarinic effects of antihistamines: Quantitative evaluation by receptor-binding assay. Jpn J. Pharmacol. 43, 277\u2013282 (1987).","journal-title":"Jpn J. Pharmacol."},{"key":"89434_CR19","doi-asserted-by":"publisher","first-page":"D1438","DOI":"10.1093\/nar\/gkad944","volume":"52","author":"SD Harding","year":"2024","unstructured":"Harding, S. D. et al. The IUPHAR\/BPS guide to PHARMACOLOGY in 2024. Nucleic Acids Res. 52, D1438\u2013D1449 (2024).","journal-title":"Nucleic Acids Res."},{"key":"89434_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10158-008-0068-4","volume":"8","author":"AK Jones","year":"2008","unstructured":"Jones, A. K. & Sattelle, D. B. The cys-loop ligand-gated ion channel gene superfamily of the nematode, Caenorhabditis elegans. Invert. Neurosci. 8, 41\u201347 (2008).","journal-title":"Invert. Neurosci."},{"key":"89434_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0166-6851(01)00400-5","volume":"119","author":"FF Hamdan","year":"2002","unstructured":"Hamdan, F. F. et al. A novel Schistosoma mansoni G protein-coupled receptor is responsive to histamine. Mol. Biochem. Parasitol. 119, 75\u201386 (2002).","journal-title":"Mol. Biochem. Parasitol."},{"key":"89434_CR22","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.ijpara.2010.04.006","volume":"40","author":"F El-Shehabi","year":"2010","unstructured":"El-Shehabi, F. & Ribeiro, P. Histamine signalling in Schistosoma mansoni: Immunolocalisation and characterisation of a new histamine-responsive receptor (SmGPR-2). Int. J. Parasitol. 40, 1395\u20131406 (2010).","journal-title":"Int. J. Parasitol."},{"key":"89434_CR23","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1007\/s00044-011-9556-x","volume":"21","author":"AV Narsaiah","year":"2012","unstructured":"Narsaiah, A. V. & Narsimha, P. Efficient synthesis of antihistamines clocinizine and chlorcyclizine. Med. Chem. Res. 21, 538\u2013541 (2012).","journal-title":"Med. Chem. Res."},{"key":"89434_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2174\/1570178615666180110161450","volume":"15","author":"T Yu","year":"2018","unstructured":"Yu, T. et al. A novel synthetic approach to diarylmethylpiperazine drugs. Lett. Org. Chem. 15, 485\u2013490 (2018).","journal-title":"Lett. Org. Chem."},{"key":"89434_CR25","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1055\/s-0036-1588533","volume":"28","author":"H Liang","year":"2017","unstructured":"Liang, H. et al. Synthesis of cyanamides from cyanogen bromide under mild conditions through N-cyanation of allylic tertiary amines. Synlett 28, 2675\u20132679 (2017).","journal-title":"Synlett"},{"key":"89434_CR26","doi-asserted-by":"publisher","first-page":"115924","DOI":"10.1016\/j.bmc.2020.115924","volume":"30","author":"MF Corr\u00eaa","year":"2021","unstructured":"Corr\u00eaa, M. F. et al. Novel potent (dihydro)benzofuranyl piperazines as human histamine receptor ligands - functional characterization and modeling studies on H3 and H4 receptors. Bioorg. Med. Chem. 30, 115924 (2021).","journal-title":"Bioorg. Med. Chem."},{"key":"89434_CR27","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jsps.2023.05.014","volume":"31","author":"MT Varela","year":"2023","unstructured":"Varela, M. T., Romanelli, M., Amaral, M., Tempone, A. G. & Fernandes, J. P. Piperazine amides with desirable solubility, physicochemical and drug-like properties: Synthesis and evaluation of the anti-Trypanosoma cruzi activity. Saudi Pharm. J. 31, 1265\u20131273 (2023).","journal-title":"Saudi Pharm. J."},{"key":"89434_CR28","doi-asserted-by":"crossref","unstructured":"Mengarda, A. C. et al. Licarin A, a neolignan isolated from Nectandra oppositifolia Nees & Mart. (Lauraceae), exhibited moderate preclinical efficacy against Schistosoma mansoni infection. Phytother. Res. 35, 5154\u20135162 (2021).","DOI":"10.1002\/ptr.7184"},{"key":"89434_CR29","doi-asserted-by":"publisher","first-page":"40890","DOI":"10.1021\/acsomega.3c06111","volume":"8","author":"VC Rocha","year":"2023","unstructured":"Rocha, V. C. et al. Evaluating the antischistosomal activity of dehydrodieugenol B and its methyl ether isolated from Nectandra leucantha-a preclinical study against Schistosoma mansoni infection. ACS Omega. 8, 40890\u201340897 (2023).","journal-title":"ACS Omega"},{"key":"89434_CR30","doi-asserted-by":"publisher","first-page":"105371","DOI":"10.1016\/j.ejps.2020.105371","volume":"150","author":"CR Amorim","year":"2020","unstructured":"Amorim, C. R. et al. Schiff bases of 4-phenyl-2-aminothiazoles as hits to new antischistosomals: Synthesis, in vitro, in vivo and in silico studies. Eur. J. Pharm. Sci. 150, 105371 (2020).","journal-title":"Eur. J. Pharm. Sci."},{"key":"89434_CR31","doi-asserted-by":"publisher","first-page":"19320","DOI":"10.1038\/s41598-022-23110-2","volume":"12","author":"JR Brito","year":"2022","unstructured":"Brito, J. R. et al. Neolignans isolated from Saururus cernuus L. (Saururaceae) exhibit efficacy against Schistosoma mansoni. Sci. Rep. 12, 19320 (2022).","journal-title":"Sci. Rep."},{"key":"89434_CR32","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1007\/s00436-020-06963-2","volume":"120","author":"L Queiroz","year":"2021","unstructured":"Queiroz, L. et al. In vitro and in vivo evaluation of cnicin from blessed thistle (Centaurea benedicta) and its inclusion complexes with cyclodextrins against Schistosoma mansoni. Parasitol. Res. 120, 1321\u20131333 (2021).","journal-title":"Parasitol. Res."},{"key":"89434_CR33","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1021\/acs.jnatprod.0c01050","volume":"83","author":"DP Sessa","year":"2020","unstructured":"Sessa, D. P. et al. 15\u03b2-Senecioyl-oxy-ent-kaur-16-en-19-oic acid, a diterpene isolated from Baccharis Lateralis, as promising oral compound for the treatment of schistosomiasis. J. Nat. Prod. 83, 3744\u20133750 (2020).","journal-title":"J. Nat. Prod."},{"key":"89434_CR34","doi-asserted-by":"publisher","first-page":"156045","DOI":"10.1016\/j.phymed.2024.156045","volume":"135","author":"DCS Souza","year":"2024","unstructured":"Souza, D. C. S. et al. In vivo antischistosomal efficacy of PorPonderosaderosa \u03b3-lactones. Phytomedicine 135, 156045 (2024).","journal-title":"Phytomedicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89434-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89434-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89434-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:58:13Z","timestamp":1757444293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89434-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89434"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89434-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the ARRIVE guidelines and approved by the Committee for the Ethical Use of Animals in Experimentation at Guarulhos University (Guarulhos, SP, Brazil) under protocol number #065\/24. All methods were performed in accordance with the relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"30816"}}